| Presented by: | North American Center for Continuing Medical Education ( NACCME) |
| Lecturer | William J. Elliott, MD, PhD, Joel M. Neutel, MD and Jeffrey D. Dunn, PharmD, MBA |
| Approximate duration: | 1 hr. |
| Summary points: | In this audiovisual CME programme, a panel of experts discusses the role of combination therapy and the importance of renin-angiotensin-aldosterone system blockade in hypertensive diabetic patients, and describes the health and economic implications of poor adherence to antihypertensive therapy. |
| Accreditation: | North American Center for Continuing Medical Education ( NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-999-09-009-H01-P).
Expiration Date: October 8, 2010. |
| Other: | |
E-Mail this webcast/CME to a colleague
Optimizing Antihypertensive Therapy and Health and Economic Outcomes in a Managed Care Environment
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
